{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:14:35Z","timestamp":1790518475210,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12933-018-0766-0","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T04:33:11Z","timestamp":1535430791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?"],"prefix":"10.1186","volume":"17","author":[{"given":"Alexander","family":"Tenenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7055-4488","authenticated-orcid":false,"given":"Enrique Z.","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","volume":"3","author":"T Aung","year":"2018","unstructured":"Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks. JAMA Cardiol. 2018;3:225\u201334.","journal-title":"JAMA Cardiol."},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"CD003177","DOI":"10.1002\/14651858.cd003177.pub3","volume":"7","author":"AS Abdelhamid","year":"2018","unstructured":"Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Al Abdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Syst Rev. 2018;7:CD003177. \n                    https:\/\/doi.org\/10.1002\/14651858.cd003177.pub3\n                    \n                  .","journal-title":"Cochrane Database of Syst Rev"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12970-018-0222-2","volume":"15","author":"APT Fayh","year":"2018","unstructured":"Fayh APT, Borges K, Cunha GS, Krause M, Rocha R, de Bittencourt PIH, Moreira JCF, Friedman R, da Silva Rossato J, Fernandes JR, et al. Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial. J Int Soc Sports Nutr. 2018;15:18.","journal-title":"J Int Soc Sports Nutr"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12933-017-0523-9","volume":"16","author":"M Poreba","year":"2017","unstructured":"Poreba M, Mostowik M, Siniarski A, Golebiowska-Wiatrak R, Malinowski KP, Haberka M, Konduracka E, Nessler J, Undas A, Gajos G. Treatment with high-dose n-3PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes. Cardiovasc Diabetol. 2017;16:50.","journal-title":"Cardiovasc Diabetol."},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-018-0740-x","volume":"17","author":"LL O\u2019Mahoney","year":"2018","unstructured":"O\u2019Mahoney LL, Matu J, Price OJ, Birch KM, Ajjan RA, Farrar D, Tapp R, West DJ, Deighton K, Campbell MD. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol. 2018;17:98.","journal-title":"Cardiovasc Diabetol."},{"key":"766_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-016-0437-y","volume":"15","author":"T Sawada","year":"2016","unstructured":"Sawada T, Tsubata H, Hashimoto N, Takabe M, Miyata T, Aoki K, Yamashita S, Oishi S, Osue T, Yokoi K, Tsukishiro Y, Onishi T, Shimane A, Taniguchi Y, Yasaka Y, Ohara T, Kawai H, Yokoyama M. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial. Cardiovasc Diabetol. 2016;15:121.","journal-title":"Cardiovasc Diabetol."},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clinthera.2017.11.007","volume":"40","author":"CH Kim","year":"2018","unstructured":"Kim CH, Han KA, Yu J, Lee SH, Jeon HK, Kim SH, Kim SY, Han KH, Won K, Kim DB, Lee KJ, Min K, Byun DW, Lim SW, Ahn CW, Kim S, Hong YJ, Sung J, Hur SH, Hong SJ, Lim HS, Park IB, Kim IJ, Lee H, Kim HS. Efficacy and safety of adding omega-3 fatty acids in statin-treated patients with residual hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a randomized, double-blind, and placebo-controlled trial. Clin Ther. 2018;40:83\u201394.","journal-title":"Clin Ther"},{"issue":"7","key":"766_CR8","doi-asserted-by":"publisher","first-page":"e004740","DOI":"10.1161\/JAHA.116.004740","volume":"6","author":"TK Elajami","year":"2017","unstructured":"Elajami TK, Alfaddagh A, Lakshminarayan D, Soliman M, Chandnani M, Welty FK. Eicosapentaenoic and docosahexaenoic acids attenuate progression of albuminuria in patients with type 2 diabetes mellitus and coronary artery disease. J Am Heart Assoc. 2017;6(7):e004740. \n                    https:\/\/doi.org\/10.1161\/jaha.116.004740\n                    \n                  .","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"766_CR9","doi-asserted-by":"publisher","first-page":"E573","DOI":"10.3390\/nu9060573","volume":"9","author":"MG Jacobo-Cejudo","year":"2017","unstructured":"Jacobo-Cejudo MG, Vald\u00e9s-Ramos R, Guadarrama-L\u00f3pez AL, Pardo-Morales RV, Mart\u00ednez-Carrillo BE, Harbige LS. Effect of n-3 polyunsaturated fatty acid supplementation on metabolic and inflammatory biomarkers in type 2 diabetes mellitus patients. Nutrients. 2017;9(6):E573. \n                    https:\/\/doi.org\/10.3390\/nu9060573\n                    \n                  .","journal-title":"Nutrients"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-016-0454-x","volume":"15","author":"PG J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen PG, Jensen MT, Biering-S\u00f8rensen T, Mogelvang R, Galatius S, Fritz-Hansen T, Rossing P, Vilsb\u00f8ll T, Jensen JS. Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes. Cardiovasc Diabetol. 2016;15:137.","journal-title":"Cardiovasc Diabetol."},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/CIRCOUTCOMES.115.002104","volume":"9","author":"R Klempfner","year":"2016","unstructured":"Klempfner R, Erez A, Sagit BZ, Goldenberg I, Fisman E, Kopel E, Shlomo N, Israel A, Tenenbaum A. Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease: twenty-two-year follow-up of the bezafibrate infarction prevention study and registry. Circ Cardiovasc Qual Outcomes. 2016;9:100\u20138.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12933-016-0415-4","volume":"15","author":"P Valensi","year":"2016","unstructured":"Valensi P, Avignon A, Sultan A, Chanu B, Nguyen MT, Cosson E. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2016;15:104.","journal-title":"Cardiovasc Diabetol."},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-016-0380-y","volume":"15","author":"A Leon-Acu\u00f1a","year":"2016","unstructured":"Leon-Acu\u00f1a A, Alcala-Diaz JF, Delgado-Lista J, Torres-Pe\u00f1a JD, Lopez-Moreno J, Camargo A, Garcia-Rios A, Marin C, Gomez-Delgado F, Caballero J, Van-Ommen B, Malagon MM, Perez-Martinez P, Lopez-Miranda J. Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study. Cardiovasc Diabetol. 2016;15:68.","journal-title":"Cardiovasc Diabetol."},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","volume":"106","author":"PM Kris-Etherton","year":"2002","unstructured":"Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association. Nutrition C Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747\u201357.","journal-title":"Circulation"},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bbalip.2011.10.011","volume":"1821","author":"GC Shearer","year":"2012","unstructured":"Shearer GC, Savinova OV, Harris WS. Fish oil\u2014how does it reduce plasma triglycerides? Biochim Biophys Acta. 2012;1821:843\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.11.008","volume":"197","author":"WS Harris","year":"2008","unstructured":"Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008;197:12\u201324.","journal-title":"Atherosclerosis."},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jnutbio.2009.12.004","volume":"21","author":"Y Adkins","year":"2010","unstructured":"Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010;21:781\u201392.","journal-title":"J Nutr Biochem"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1194\/jlr.R027904","volume":"53","author":"DB Jump","year":"2012","unstructured":"Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases. J Lipid Res. 2012;53:2525\u201345.","journal-title":"J Lipid Res"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4158\/EP161445.RA","volume":"23","author":"Y Handelsman","year":"2017","unstructured":"Handelsman Y, Shapiro MD. Triglycerides, atherosclerosis, and cardiovascular outcome studies: focus on omega-3 fatty acids. Endocr Pract. 2017;23:100\u201312.","journal-title":"Endocr Pract."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-018-0766-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T19:08:19Z","timestamp":1566932899000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-018-0766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s12933-018-0766-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"119"}}